Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
FutureFuel Releases Third Quarter 2025 Results
-
Rigetti Computing Reports Third Quarter 2025 Financial Results; Provides Technology Roadmap Updates for 2026 and 2027
-
Solo Brands, Inc. to Present and Host 1x1 Meetings at the 17th Annual Southwest IDEAS Investor Conference on November 19, 2025
-
Perspective Therapeutics Provides Recent Business Highlights and Reports 3Q 2025 Results
-
electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
-
SKYX Announces Corporate Update Call Including New Developments
-
CapsoVision Submits Breakthrough Device Designation Application to FDA for Pancreatic Cancer Screening Capsule
-
Life360 Reports Record Q3 2025 Results
-
Zentalis Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operational Progress
-
TeraWulf Reports Third Quarter 2025 Results
-
Terns Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
-
The RealReal Announces Third Quarter 2025 Results
-
Mobile Infrastructure Reports Third Quarter 2025 Financial Results
-
Gemini Reports Third Quarter 2025 Results
-
Annexon Reports Third Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones
-
HF Foods Reports Solid Third Quarter 2025 Financial Results
-
Outset Medical Reports Third-Quarter Results
-
Kaltura Signs Definitive Agreement to Acquire eSelf.ai, a provider of AI-based Interactive Avatars
-
Assembly Biosciences Reports Third Quarter 2025 Financial Results and Recent Updates
-
Varonis to Present at Upcoming Investor Conferences
-
Coherent Unveils EDGE CUT20 OEM Cutting Solution for Intelligent Metal Cutting at Photonix Japan 2025
-
Oculis Reports Q3 2025 Financial Results and Provides Company Update
-
Natural Gas Services Group, Inc. Reports Third Quarter 2025 Financial and Operating Results; Increases 2025 Adjusted EBITDA Guidance
-
Health Catalyst Reports Third Quarter 2025 Results
-
FibroGen Reports Third Quarter 2025 Financial Results and Provides Business Update
-
Celldex Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
Capricor Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
Vor Bio Announces Proposed Public Offering of $100 Million of Common Stock
-
Cogent Biosciences Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2031 and Common Stock
-
Skye Bioscience Reports Third Quarter 2025 Financial Results and Business Update
-
Nkarta Reports Third Quarter 2025 Financial Results and Corporate Highlights
-
Mereo BioPharma Reports Third Quarter 2025 Financial Results and Provides Corporate Highlights
-
Plug Power Third Quarter 2025 Highlights
-
Gevo Reports Third Quarter 2025 Financial Results
-
MIMEDX to Participate in Upcoming Investor Conferences
-
Datavault AI Inc. (NASDAQ: DVLT) Issues Investor Update Highlighting Continued Revenue Growth, Strategic Partnerships, and Global Expansion
-
Herzfeld Credit Income Fund, Inc. Declares Year-End Distribution in Stock and Cash; Fund Updates
-
TG Therapeutics to Participate in the TD Cowen Immunology & Inflammation Summit
-
byNordic Acquisition Corporation Announces Extension of Deadline to Complete Business Combination
-
Prison Fellowship Issues Statement on Supreme Court Case Landor vs. Louisiana Department of Corrections and Public Safety
-
FITNESS CHAMPS HOLDINGS LIMITED ANNOUNCES RECEIPT OF NASDAQ NOTIFICATION LETTER REGARDING MINIMUM PRICE DEFICIENCY
-
Purple Merges with Splash Access, Enhancing Global Connectivity Platforms
-
Vaalco Energy, Inc. Declares Fourth Quarter 2025 Dividend
-
Toll Brothers Opens Model Homes in ParkVue on the Platte Luxury Townhome Community in Littleton, Colorado
-
Sixty Music Announces the Upcoming Release of “We Ride The Yard”
-
Meet the Holiday Gift Winning Over Parents and Topping Tweens’ Wish Lists
-
Glass Officially Launches the City of South San Francisco’s Government E-Commerce Platform — a First for Silicon Valley
-
Intellia Therapeutics Presents Positive Longer-Term Phase 1 Data of Nexiguran Ziclumeran (nex-z) in Patients with Transthyretin (ATTR) Amyloidosis with Cardiomyopathy
-
LaFontaine Automotive Holiday Giving Program Supporting Child Safety Education
-
Phoenix Energy Announces Q3 2025 Earnings Call

